Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liusheng Huang

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control StudyMichelle E Roh, Issaka Zongo, Alassane Haro, et al.
Clinical Pharmacology and Therapeutics|October 19, 2022
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in UgandaKatherine Kay, Justin Goodwin, Hanna Ehrlich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2017
Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant RecipientsVijay Ivaturi, Christopher C Dvorak, Danna Chan, et al.
Plos Medicine|August 6, 2014
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialVictor Bigira, James Kapisi, Tamara D Clark, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySunil Parikh, Fatai Fehintola, Liusheng Huang, et al.
AIDS (London, England)|December 11, 2014
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trialMoses R Kamya, James Kapisi, Victor Bigira, et al.
Nature Communications|November 19, 2021
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan childrenErika Wallender, Ali Mohamed Ali, Emma Hughes, et al.
The American Journal of Tropical Medicine and Hygiene|October 20, 2020
Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Falciparum Malaria in Northern ZambiaMatthew M Ippolito, Julia C Pringle, Mwiche Siame, et al.
The Journal of Infectious Diseases|October 3, 2017
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in UgandaMelissa D Conrad, Daniel Mota, Marissa Foster, et al.
Pharmaceutics|November 26, 2022
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Belen P Solans, Ying Lu, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control StudyMichelle E Roh, Issaka Zongo, Alassane Haro, et al.
Clinical Pharmacology and Therapeutics|October 19, 2022
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in UgandaKatherine Kay, Justin Goodwin, Hanna Ehrlich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2017
Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant RecipientsVijay Ivaturi, Christopher C Dvorak, Danna Chan, et al.
Plos Medicine|August 6, 2014
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialVictor Bigira, James Kapisi, Tamara D Clark, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySunil Parikh, Fatai Fehintola, Liusheng Huang, et al.
AIDS (London, England)|December 11, 2014
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trialMoses R Kamya, James Kapisi, Victor Bigira, et al.
Nature Communications|November 19, 2021
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan childrenErika Wallender, Ali Mohamed Ali, Emma Hughes, et al.
The American Journal of Tropical Medicine and Hygiene|October 20, 2020
Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Falciparum Malaria in Northern ZambiaMatthew M Ippolito, Julia C Pringle, Mwiche Siame, et al.
The Journal of Infectious Diseases|October 3, 2017
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in UgandaMelissa D Conrad, Daniel Mota, Marissa Foster, et al.
Pharmaceutics|November 26, 2022
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Belen P Solans, Ying Lu, et al.
Pageof 8